Pulmonary aspergillosis: diagnosis and treatment
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA). IPA affects immunocompromised populations, which are increasing in number and...
Main Authors: | Frederic Lamoth, Thierry Calandra |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2022-11-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/31/166/220114.full |
Similar Items
-
Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?
by: Aleksandra Barac, et al.
Published: (2023-11-01) -
Invasive Pulmonary Aspergillosis
by: Marie-Pierre Ledoux, et al.
Published: (2023-01-01) -
Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
by: Armani M. Hawes, et al.
Published: (2022-11-01) -
Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
by: Ali Nuh, et al.
Published: (2022-02-01) -
Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment-naïve subjects with chronic pulmonary aspergillosis
by: Inderpaul Singh Sehgal, et al.
Published: (2023-04-01)